An Approach to Investigations of Chronic Liver Disease
- PMID: 37702974
- DOI: 10.1007/s12098-023-04751-1
An Approach to Investigations of Chronic Liver Disease
Abstract
Chronic liver disease (CLD) in children is more diverse compared to adults with respect to the etiology, progression and response to therapy. After history and clinical examination, the first step is to confirm the presence of CLD with basic blood investigations and ultrasonography. Markers of portal hypertension are splenomegaly, increased portal vein diameter, thrombocytopenia and presence of varices on endoscopy. The next step is to evaluate the etiology of CLD which will depend on the age of the child and needs targeted investigations as metabolic and inherited causes predominate in early childhood. CLD progression ought to be monitored regularly and several non-invasive markers are available but they have to be evaluated further in children. Since CLD progresses, complications have to be detected early not only to initiate appropriate treatment but also to prognosticate.
Keywords: Ascites; Chronic liver disease; Cirrhosis; Liver function tests; Portal hypertension; Variceal bleeding.
© 2023. The Author(s), under exclusive licence to Dr. K C Chaudhuri Foundation.
Similar articles
-
Clinical and laboratory predictors of esophageal varices in children and adolescents with portal hypertension syndrome.J Pediatr Gastroenterol Nutr. 2008 Feb;46(2):178-83. doi: 10.1097/MPG.0b013e318156ff07. J Pediatr Gastroenterol Nutr. 2008. PMID: 18223377
-
Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis.Dig Liver Dis. 2018 Aug;50(8):839-844. doi: 10.1016/j.dld.2018.01.132. Epub 2018 Jan 31. Dig Liver Dis. 2018. PMID: 29429910
-
Etiological spectrum of esophageal varices due to portal hypertension in Indian children: is it different from the West?J Gastroenterol Hepatol. 2008 Sep;23(9):1354-7. doi: 10.1111/j.1440-1746.2007.05102.x. Epub 2007 Aug 6. J Gastroenterol Hepatol. 2008. PMID: 17683492
-
The portal hypertension syndrome: etiology, classification, relevance, and animal models.Hepatol Int. 2018 Feb;12(Suppl 1):1-10. doi: 10.1007/s12072-017-9827-9. Epub 2017 Oct 24. Hepatol Int. 2018. PMID: 29064029 Review.
-
Prophylactic endoscopic sclerotherapy in patients with liver cirrhosis, portal hypertension, and esophageal varices.Hepatogastroenterology. 1997 May-Jun;44(15):625-36. Hepatogastroenterology. 1997. PMID: 9222663 Review.
Cited by
-
Primary and Secondary Prophylaxis of Gastrointestinal Bleeding in Children with Portal Hypertension: A Multicenter National Study by SIGENP.Children (Basel). 2025 Jul 17;12(7):940. doi: 10.3390/children12070940. Children (Basel). 2025. PMID: 40723134 Free PMC article.
-
Assessment of normal portal vein diameter in children and adolescents on abdominal contrast-enhanced CT.Abdom Radiol (NY). 2025 Jul;50(7):2958-2968. doi: 10.1007/s00261-024-04755-1. Epub 2024 Dec 24. Abdom Radiol (NY). 2025. PMID: 39718629
References
-
- European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406–60.
-
- Fawaz R, Baumann U, Ekong U, et al. Guideline for the evaluation of cholestatic jaundice in infants: Joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2017;64:154–68. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources